Bank OZK’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $528K | Sell |
18,796
-991
| -5% | -$26.4K | 0.19% | 101 |
|
|
2025
Q4 | $493K | Buy |
19,787
+659
| +3% | +$16.6K | 0.17% | 109 |
|
|
2025
Q3 | $487K | Sell |
19,128
-933
| -5% | -$23K | 0.17% | 104 |
|
|
2025
Q2 | $486K | Sell |
20,061
-1,217
| -6% | -$28.4K | 0.19% | 101 |
|
|
2025
Q1 | $539K | Sell |
21,278
-3,146
| -13% | -$82.3K | 0.22% | 95 |
|
|
2024
Q4 | $648K | Sell |
24,424
-607
| -2% | -$16.5K | 0.27% | 89 |
|
|
2024
Q3 | $724K | Sell |
25,031
-1,955
| -7% | -$57K | 0.3% | 88 |
|
|
2024
Q2 | $755K | Sell |
26,986
-2,215
| -8% | -$61K | 0.33% | 86 |
|
|
2024
Q1 | $810K | Sell |
29,201
-2,505
| -8% | -$69.5K | 0.36% | 85 |
|
|
2023
Q4 | $913K | Sell |
31,706
-4,163
| -12% | -$126K | 0.45% | 74 |
|
|
2023
Q3 | $1.19M | Sell |
35,869
-17,194
| -32% | -$608K | 0.65% | 55 |
|
|
2023
Q2 | $1.95M | Sell |
53,063
-12,132
| -19% | -$472K | 0.93% | 32 |
|
|
2023
Q1 | $2.66M | Sell |
65,195
-1,719
| -3% | -$74.2K | 1.32% | 23 |
|
|
2022
Q4 | $3.43M | Sell |
66,914
-991
| -1% | -$47.5K | 1.7% | 19 |
|
|
2022
Q3 | $2.97M | Sell |
67,905
-297
| -0.4% | -$14.4K | 1.61% | 20 |
|
|
2022
Q2 | $3.58M | Sell |
68,202
-607
| -0.9% | -$30.9K | 1.81% | 14 |
|
|
2022
Q1 | $3.56M | Sell |
68,809
-74
| -0.1% | -$3.84K | 1.53% | 20 |
|
|
2021
Q4 | $4.07M | Buy |
68,883
+195
| +0.3% | +$9.66K | 1.66% | 15 |
|
|
2021
Q3 | $2.95M | Sell |
68,688
-1,825
| -3% | -$80.8K | 1.34% | 23 |
|
|
2021
Q2 | $2.76M | Sell |
70,513
-20,310
| -22% | -$790K | 1.22% | 30 |
|
|
2021
Q1 | $3.29M | Sell |
90,823
-487
| -0.5% | -$17.3K | 1.51% | 20 |
|
|
2020
Q4 | $3.36M | Sell |
91,310
-2,980
| -3% | -$109K | 1.65% | 18 |
|
|
2020
Q3 | $3.28M | Buy |
94,290
+7,302
| +8% | +$256K | 1.75% | 14 |
|
|
2020
Q2 | $2.7M | Buy |
86,988
+2,123
| +3% | +$72.1K | 1.53% | 17 |
|
|
2020
Q1 | $2.63M | Buy |
84,865
+1,171
| +1% | +$39.9K | 1.44% | 14 |
|
|
2019
Q4 | $3.11M | Buy |
83,694
+4,710
| +6% | +$168K | 1.23% | 22 |
|
|
2019
Q3 | $2.69M | Sell |
78,984
-526
| -0.7% | -$19.1K | 1.19% | 20 |
|
|
2019
Q2 | $3.27M | Sell |
79,510
-1,329
| -2% | -$52.8K | 1.42% | 13 |
|
|
2019
Q1 | $3.26M | Buy |
80,839
+5,740
| +8% | +$230K | 1.42% | 13 |
|
|
2018
Q4 | $3.11M | Sell |
75,099
-111
| -0.1% | -$4.61K | 1.57% | 15 |
|
|
2018
Q3 | $3.15M | Sell |
75,210
-1,180
| -2% | -$45.4K | 1.25% | 16 |
|
|
2018
Q2 | $2.63M | Buy |
76,390
+488
| +0.6% | +$16.7K | 1.03% | 18 |
|
|
2018
Q1 | $2.56M | Buy |
75,902
+2,518
| +3% | +$86.6K | 1.01% | 19 |
|
|
2017
Q4 | $2.52M | Buy |
73,384
+14,470
| +25% | +$493K | 0.96% | 20 |
|
|
2017
Q3 | $2M | Sell |
58,914
-495
| -0.8% | -$15.9K | 0.82% | 24 |
|
|
2017
Q2 | $1.89M | Sell |
59,409
-1,756
| -3% | -$55.4K | 0.68% | 26 |
|
|
2017
Q1 | $1.99M | Sell |
61,165
-1,259
| -2% | -$39.7K | 0.64% | 24 |
|
|
2016
Q4 | $1.92M | Sell |
62,424
-6,573
| -10% | -$201K | 0.63% | 23 |
|
|
2016
Q3 | $2.22M | Buy |
68,997
+1,550
| +2% | +$51.8K | 0.8% | 21 |
|
|
2016
Q2 | $2.25M | Sell |
67,447
-2,192
| -3% | -$70K | 0.82% | 20 |
|
|
2016
Q1 | $1.96M | Buy |
69,639
+1,370
| +2% | +$39.1K | 0.71% | 19 |
|
|
2015
Q4 | $2.09M | Buy |
68,269
+2,659
| +4% | +$83.7K | 0.73% | 18 |
|
|
2015
Q3 | $1.96M | Buy |
65,610
+2,964
| +5% | +$95K | 0.74% | 17 |
|
|
2015
Q2 | $1.99M | Buy |
62,646
+2,685
| +4% | +$87.5K | 0.69% | 17 |
|
|
2015
Q1 | $1.98M | Buy |
59,961
+348
| +0.6% | +$11.1K | 0.71% | 20 |
|
|
2014
Q4 | $1.76M | Buy |
59,613
+2,339
| +4% | +$67.1K | 0.61% | 22 |
|
|
2014
Q3 | $1.61M | Sell |
57,274
-815
| -1% | -$22.9K | 0.6% | 24 |
|
|
2014
Q2 | $1.64M | Buy |
58,089
+532
| +0.9% | +$15.2K | 0.57% | 25 |
|
|
2014
Q1 | $1.75M | Sell |
57,557
-3,827
| -6% | -$114K | 0.63% | 21 |
|
|
2013
Q4 | $1.78M | Buy |
61,384
+1,969
| +3% | +$57.3K | 0.69% | 20 |
|
|
2013
Q3 | $1.62M | Buy |
59,415
+18,540
| +45% | +$504K | 0.7% | 20 |
|
|
2013
Q2 | $1.09M | Buy |
+40,875
| New | +$1.13M | 0.8% | 14 |
|
Other funds holding PFE
VCM
VPM
Bank OZK's PFE Position: Q1 2026 in Review
Bank OZK reduced its Pfizer (PFE) stake by 5% in Q1 2026, selling an estimated $26.4K and leaving 18,796 shares worth $528K. The position accounts for 0.19% of the portfolio, ranked #101.
Bank OZK first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.07M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bank OZK held 18,796 shares of Pfizer worth $528K as of Q1 2026.
- Bank OZK sold 991 Pfizer shares in Q1 2026, an estimated $26.4K.
- Pfizer made up 0.19% of Bank OZK's portfolio in Q1 2026, its #101 holding.
- Bank OZK first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bank OZK's Pfizer position peaked at $4.07M in Q4 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bank OZK's 13F filing for Q1 2026, filed 13 May 2026.